New Drugs in Primary Care: Lessons Learned From COVID-19

"Although the details are not important for prescribing internists, having a basic understanding of the mechanism of action can help [us] better understand for which patients the drugs are indicated."

Related Keywords

Boston ,Massachusetts ,United States ,Israel ,Israeli ,Hubertus Kiefl ,Gerald Smetana ,American College Of Physicians ,Beth Israel Deaconess Medical Center ,Harvard Medical School ,American College ,Interactions Checker ,Coronavirus ,019 Novel Coronavirus ,019 Ncov ,Uhan Coronavirus ,Uman Coronavirus Hku1 ,Uman Coronavirus Oc43 ,Cov Oc43 ,Uman Coronavirus 229e ,Cov 229e ,Drug Interactions ,Primary Care ,Pregnancy ,Antiviral ,Amciclovir ,Alacyclovir ,Protease Inhibitor ,Atazanavir ,Darunavir ,Ipranavir ,Biologic Therapy ,Monoclonal Antibody ,Etuximab ,Ituximab ,Proteases ,Patient Safety ,Treatment Guidelines ,Hi ,